Walleye Trading’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$494K Buy
91,500
+12,400
+16% +$74.2K ﹤0.01% 2598
2025
Q4
$550K Buy
79,100
+17,600
+29% +$116K ﹤0.01% 2768
2025
Q3
$397K Buy
61,500
+27,400
+80% +$187K ﹤0.01% 2902
2025
Q2
$227K Sell
34,100
-2,000
-6% -$10.3K ﹤0.01% 3169
2025
Q1
$234K Sell
36,100
-587,200
-94% -$4.22M ﹤0.01% 3000
2024
Q4
$5.02M Buy
623,300
+11,300
+2% +$93.2K 0.01% 1141
2024
Q3
$4.99M Buy
612,000
+35,400
+6% +$233K 0.01% 1145
2024
Q2
$4.02M Sell
576,600
-1,748,400
-75% -$13.2M 0.01% 1177
2024
Q1
$24.7M Buy
2,325,000
+466,300
+25% +$4.08M 0.05% 343
2023
Q4
$14.9M Buy
1,858,700
+775,400
+72% +$5.65M 0.03% 580
2023
Q3
$8.9M Buy
1,083,300
+1,008,100
+1,341% +$8.69M 0.02% 746
2023
Q2
$602K Sell
75,200
-143,100
-66% -$1.06M ﹤0.01% 2601
2023
Q1
$1.77M Buy
218,300
+113,600
+109% +$912K ﹤0.01% 1774
2022
Q4
$658K Buy
104,700
+24,600
+31% +$172K ﹤0.01% 2586
2022
Q3
$552K Sell
80,100
-175,900
-69% -$1.22M ﹤0.01% 2808
2022
Q2
$2.14M Buy
256,000
+30,000
+13% +$419K 0.01% 1622
2022
Q1
$5.16M Sell
226,000
-7,000
-3% -$171K 0.02% 988
2021
Q4
$6.43M Buy
233,000
+8,500
+4% +$228K 0.02% 832
2021
Q3
$6.25M Sell
224,500
-107,300
-32% -$3.04M 0.02% 807
2021
Q2
$9.73M Sell
331,800
-78,700
-19% -$2.38M 0.04% 451
2021
Q1
$13M Sell
410,500
-87,000
-17% -$2.55M 0.06% 237
2020
Q4
$10.3M Buy
497,500
+311,600
+168% +$5.81M 0.05% 380
2020
Q3
$2.89M Sell
185,900
-69,900
-27% -$1.2M 0.02% 892
2020
Q2
$4.68M Sell
255,800
-156,400
-38% -$2.76M 0.03% 568
2020
Q1
$6.39M Sell
412,200
-688,100
-63% -$16.6M 0.05% 312
2019
Q4
$32.9M Sell
1,100,300
-210,100
-16% -$5.46M 0.23% 65
2019
Q3
$28.6M Buy
1,310,400
+310,800
+31% +$7.11M 0.24% 42
2019
Q2
$25.2M Buy
999,600
+15,300
+2% +$363K 0.22% 53
2019
Q1
$24.3M Sell
984,300
-899,900
-48% -$21.5M 0.19% 64
2018
Q4
$34.8M Sell
1,884,200
-76,300
-4% -$1.81M 0.26% 45
2018
Q3
$50.3M Sell
1,960,500
-2,931,700
-60% -$67.1M 0.27% 46
2018
Q2
$114M Sell
4,892,200
-2,077,800
-30% -$43M 0.61% 14
2018
Q1
$111M Buy
6,970,000
+4,023,600
+137% +$74.9M 0.64% 15
2017
Q4
$61.2K Buy
2,946,400
+531,800
+22% +$8.43M 0.3% 32
2017
Q3
$34.6K Buy
2,414,600
+1,722,000
+249% +$26M 0.17% 67
2017
Q2
$12K Buy
692,600
+394,900
+133% +$4.73M 0.07% 236
2017
Q1
$3.28K Sell
297,700
-38,400
-11% -$528K 0.02% 726
2016
Q4
$4.88M Buy
336,100
+60,400
+22% +$1.11M 0.03% 458
2016
Q3
$6.77M Buy
275,700
+6,600
+2% +$171K 0.04% 309
2016
Q2
$5.42M Buy
269,100
+78,200
+41% +$2.21M 0.04% 409
2016
Q1
$5.03M Buy
190,900
+171,600
+889% +$12.7M 0.04% 388
2015
Q4
$1.96M Buy
19,300
+5,100
+36% +$573K 0.02% 780
2015
Q3
$2.53M Buy
14,200
+12,900
+992% +$3.01M 0.02% 541
2015
Q2
$288K Buy
1,300
+600
+86% +$133K ﹤0.01% 2146
2015
Q1
$139K Sell
700
-73,600
-99% -$13.1M ﹤0.01% 2461
2014
Q4
$10.6M Buy
74,300
+69,800
+1,551% +$9.39M 0.1% 139
2014
Q3
$590K Buy
+4,500
New +$536K 0.01% 1176

Other funds holding BHC

Walleye Trading's BHC Position: Q1 2026 in Review

Walleye Trading reduced its Bausch Health (BHC) stake by 31% in Q1 2026, selling an estimated $59K and leaving 21,951 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3384.

Walleye Trading first reported a position in BHC in Q1 2016 and has held it in 27 quarters since. The position peaked at $48.3M in Q1 2018. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Walleye Trading held 21,951 shares of Bausch Health worth $119K as of Q1 2026.
  • Walleye Trading sold 9,862 Bausch Health shares in Q1 2026, an estimated $59K.
  • Bausch Health made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3384 holding.
  • Walleye Trading first reported a position in Bausch Health in Q1 2016 and has held it in 27 quarters since.
  • Walleye Trading's Bausch Health position peaked at $48.3M in Q1 2018.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.